889447689	889447689	CD	B-NP	O
|	|	NN	I-NP	O
FCMC	FCMC	NN	I-NP	O
|	|	NN	I-NP	O
83230517	83230517	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
775954	775954	CD	B-NP	O
|	|	CC	I-NP	O
1/29/2002	1/29/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
VULVAR	VULVAR	NNP	I-NP	I-protein
ABSCESS	ABSCESS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/24/2002	5/24/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/3/2002	5/3/2002	CD	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NN	I-NP	O
:	:	:	O	O
VULVAR	VULVAR	NN	B-NP	O
ABSCESS	ABSCESS	NN	I-NP	O
,	,	,	O	O
DIABETES	DIABETES	NN	B-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
VULVAR	VULVAR	NNP	B-NP	O
ABSCESS	ABSCESS	NNP	I-NP	O
,	,	,	O	O
DIABETES	DIABETES	NNP	B-NP	O
,	,	,	O	O
CORONARY	CORONARY	NNP	B-NP	O
ARTERY	ARTERY	NNP	I-NP	O
DISEASE	DISEASE	NNP	I-NP	O
,	,	,	O	O
LEFT	LEFT	NNP	B-NP	O
VENTRICULAR	VENTRICULAR	NNP	I-NP	O
SYSTOLIC	SYSTOLIC	NNP	I-NP	O
FUNCTION	FUNCTION	NNP	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
47-year-old	47-year-old	JJ	I-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
IDDM	IDDM	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
recurrent	recurrent	JJ	B-NP	O
abscesses	abscess	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
groin	groin	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
enlarging	enlarge	VBG	B-VP	O
palpable	palpable	JJ	B-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
first	first	RB	B-ADVP	O
noticed	notice	VBD	B-VP	O
a	a	DT	B-NP	O
tender	tender	NN	I-NP	O
bump	bump	NN	I-NP	O
six	six	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
GYN	GYN	NN	B-NP	O
clinic	clinic	NN	I-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
10.6	10.6	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
prescribed	prescribe	VBN	I-VP	O
a	a	DT	B-NP	O
ten-day	ten-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Levaquin	Levaquin	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
persisted	persist	VBD	B-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
chills	chill	NNS	B-NP	O
so	so	IN	B-SBAR	O
she	she	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
GYN	GYN	NN	I-NP	O
clinic	clinic	NN	I-NP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
5	5	CD	I-NP	O
x	x	SYM	I-NP	O
3	3	CD	I-NP	O
cm	cm	NN	I-NP	O
vulvar	vulvar	NN	I-NP	O
mass	mass	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
finger	finger	NN	I-NP	O
stick	stick	NN	I-NP	O
of	of	IN	B-PP	O
390	390	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Sharpon	Sharpon	NNP	I-NP	O
S	S	NNP	I-NP	O
Tlgen	Tlgen	NNP	I-NP	O
University	University	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
IV	IV	CD	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
and	and	CC	O	O
diabetic	diabetic	JJ	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
for	for	IN	B-PP	O
I	I	NNP	B-NP	O
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
by	by	IN	B-PP	O
GYN	GYN	NN	B-NP	B-protein
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL/SURGICAL	MEDICAL/SURGICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Insulin-dependent	Insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
in	in	IN	B-PP	O
1987	1987	CD	B-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
with	with	IN	B-PP	O
recently	recently	RB	B-NP	O
discontinued	discontinue	VBN	I-NP	O
Paxil	Paxil	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
current	current	JJ	I-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
flares	flare	NNS	I-NP	O
or	or	CC	I-NP	O
intubations	intubation	NNS	I-NP	O
,	,	,	O	O
hemorrhoids	hemorrhoid	NNS	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
I	I	CD	I-NP	O
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
for	for	IN	B-PP	O
left	left	JJ	B-NP	O
thigh	thigh	NN	I-NP	O
and	and	CC	I-NP	O
buttock	buttock	NN	I-NP	O
abscesses	abscess	NNS	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
TAH-LSO	TAH-LSO	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
surgery	surgery	NN	I-NP	O
for	for	IN	B-PP	O
ectopic	ectopic	JJ	B-NP	O
pregnancy	pregnancy	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
RSO	RSO	NN	I-NP	O
for	for	IN	B-PP	O
ovarian	ovarian	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
excision	excision	NN	I-NP	O
of	of	IN	B-PP	O
lingular	lingular	JJ	B-NP	O
mass	mass	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
hemorrhagic	hemorrhagic	JJ	I-NP	O
infarct	infarct	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
malignant	malignant	JJ	I-NP	B-cell_type
cells	cell	NNS	I-NP	I-cell_type
-RRB-	-RRB-	NN	I-NP	B-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
systemic	systemic	JJ	I-NP	O
biopsy	biopsy	NN	I-NP	O
for	for	IN	B-PP	O
mild	mild	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
gastritis	gastritis	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Insulin	Insulin	NN	B-NP	B-protein
70/30	70/30	CD	B-NP	I-protein
70	70	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	O
;	;	:	O	O
Nexium	Nexium	NN	B-NP	O
40	40	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Diflucan	Diflucan	NN	B-NP	O
100	100	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
DesOwen	DesOwen	NN	B-NP	O
lotion	lotion	NN	I-NP	O
;	;	:	O	O
Lac-Hydrin	Lac-Hydrin	NN	B-NP	O
lotion	lotion	NN	I-NP	O
;	;	:	O	O
Endocet	Endocet	NNP	B-NP	O
5/325	5/325	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
Levaquin	Levaquin	NN	B-NP	O
500	500	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
x	x	SYM	B-NP	O
10	10	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Codeine	Codeine	NN	B-NP	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
constipation	constipation	NN	B-NP	O
;	;	:	O	O
Demerol	Demerol	NN	B-NP	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
hallucinations	hallucination	NNS	B-NP	O
;	;	:	O	O
penicillin	penicillin	NN	B-NP	O
which	which	WDT	B-NP	O
causes	cause	VBZ	B-VP	O
hives	hive	NNS	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Breast	Breast	NN	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
and	and	CC	I-NP	O
sister	sister	NN	I-NP	O
,	,	,	O	O
ovarian	ovarian	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
paternal	paternal	JJ	I-NP	O
grandmother	grandmother	NN	I-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
borderline	borderline	JJ	B-NP	O
diabetes	diabete	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
mother	mother	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
one	one	CD	I-NP	O
pack	pack	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
smoker	smoker	NN	I-NP	O
x	x	SYM	B-NP	O
36	36	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
denies	deny	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
or	or	CC	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
extended	extend	VBN	I-NP	O
family	family	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
noncompliance	noncompliance	NN	B-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Twenty-five	Twenty-five	CD	B-NP	O
pound	pound	NN	I-NP	O
intentional	intentional	JJ	I-NP	O
weight	weight	NN	I-NP	O
loss	loss	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
two	two	CD	I-NP	O
months	month	NNS	I-NP	O
,	,	,	O	O
decreased	decrease	VBN	B-NP	O
energy	energy	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
on	on	IN	B-PP	O
climbing	climb	VBG	B-VP	O
one	one	CD	B-NP	O
flight	flight	NN	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
.	.	.	O	O

Pain	Pain	NN	B-NP	B-protein
in	in	IN	B-PP	O
legs	leg	NNS	B-NP	O
with	with	IN	B-PP	O
exercise	exercise	NN	B-NP	O
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
polyuria	polyuria	NN	I-NP	O
,	,	,	O	O
polydipsia	polydipsia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
noted	note	VBD	B-VP	O
blood	blood	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
underwear	underwear	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distant	distant	JJ	I-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
believed	believe	VBD	B-VP	O
it	it	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
hemorrhoids	hemorrhoid	NNS	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

VITAL	VITAL	JJ	B-NP	O
SIGNS	SIGNS	NN	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
98.2	98.2	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/88	140/88	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
18	18	CD	B-NP	O
,	,	,	O	O
oxygen	oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

GENERAL	GENERAL	NNP	B-NP	O
:	:	:	O	O
Obese	Obese	JJ	B-NP	O
,	,	,	I-NP	O
middle-aged	middle-aged	JJ	I-NP	O
woman	woman	NN	I-NP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

EOMI	EOMI	LS	B-LST	B-DNA
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Moist	Moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

Positive	Positive	JJ	B-NP	O
upper	upper	JJ	I-NP	O
dentures	denture	NNS	I-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
LAD	LAD	NN	I-NP	B-protein
,	,	,	O	O
thyroid	thyroid	NN	B-NP	O
not	not	RB	B-ADJP	O
palpable	palpable	JJ	I-ADJP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
S1S2	S1S2	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
at	at	IN	B-PP	O
8.0	8.0	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
positive	positive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatosplenomegaly	hepatosplenomegaly	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Tender	Tender	NN	B-NP	O
,	,	,	O	O
3.0	3.0	CD	B-NP	O
cm	cm	NN	I-NP	O
,	,	,	O	O
firm	firm	NN	B-NP	O
mobile	mobile	JJ	I-NP	O
,	,	,	I-NP	O
nonfixed	nonfixed	JJ	I-NP	O
,	,	,	I-NP	O
nonerythematous	nonerythematous	JJ	I-NP	O
question	question	NN	I-NP	O
flocculent	flocculent	JJ	I-NP	O
mass	mass	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
groin	groin	NN	I-NP	O
without	without	IN	B-PP	O
associated	associate	VBN	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
palpable	palpable	JJ	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
her	her	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
with	with	IN	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
second	second	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
refill	refill	NN	I-NP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBD	B-VP	O
x	x	NN	B-NP	B-DNA
3	3	CD	I-NP	I-DNA
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

5/5	5/5	CD	B-NP	O
strength	strength	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADJP	O
upper	upper	JJ	I-ADJP	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
.	.	.	O	O

Sensation	Sensation	NN	B-NP	O
grossly	grossly	RB	B-NP	O
intact	intact	JJ	I-NP	O
upper	upper	JJ	I-NP	O
and	and	CC	I-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
,	,	,	O	O
thought	think	VBD	B-VP	O
some	some	DT	B-NP	O
subjective	subjective	JJ	I-NP	O
altered	altered	JJ	I-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
extremities	extremity	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
48-year-old	48-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
poorly	poorly	RB	B-NP	O
controlled	control	VBN	I-NP	O
insulin-dependent	insulin-dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
initially	initially	RB	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
I	I	NNP	I-NP	O
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
left	leave	VBD	B-VP	O
vulvar	vulvar	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
acute	acute	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
after	after	IN	B-PP	O
being	be	VBG	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
insulin	insulin	NN	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
ultimately	ultimately	RB	B-VP	O
had	have	VBD	I-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
workup	workup	NN	I-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
severe	severe	JJ	B-NP	O
left	left	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
2-3	2-3	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Infectious	Infectious	JJ	I-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
vulvar	vulvar	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
gentamicin	gentamicin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
dosing	dosing	NN	I-NP	O
per	per	IN	B-PP	O
levels	level	NNS	B-NP	O
-RRB-	-RRB-	NN	B-NP	B-protein
and	and	CC	I-NP	O
clindamycin	clindamycin	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-cell_line
cultures	culture	NNS	I-NP	I-cell_line
revealed	reveal	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
vaginal	vaginal	JJ	I-NP	O
flora	flora	NN	I-NP	O
,	,	,	O	O
anaerobic	anaerobic	JJ	B-NP	O
culture	culture	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
bacteroides	bacteroide	NNS	B-NP	O
,	,	,	O	O
pepto	pepto	NN	B-NP	O
Strep	Strep	NNP	I-NP	O
and	and	CC	I-NP	O
Propionibacterium	Propionibacterium	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	IN	B-PP	O
an	an	DT	B-NP	O
I	I	NNP	I-NP	O
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
vulvar	vulvar	JJ	I-NP	O
abscess	abscess	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
2	2	CD	I-NP	O
which	which	WDT	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
or	or	CC	I-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
further	further	JJ	B-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Prive	Prive	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
and	and	CC	O	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
clindamycin	clindamycin	NN	B-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
fourteen-day	fourteen-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Diabetes	Diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
her	her	PRP$	B-NP	O
finger	finger	NN	I-NP	O
sticks	stick	NNS	I-NP	O
were	be	VBD	B-VP	O
600	600	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
15	15	CD	I-NP	O
unit	unit	NN	I-NP	O
bolus	bolus	NN	I-NP	O
with	with	IN	B-PP	O
subsequent	subsequent	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
drip	drip	NN	I-NP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
transitioned	transitione	VBD	B-VP	O
to	to	TO	B-PP	O
subcu	subcu	NN	B-NP	O
insulin	insulin	NN	I-NP	O
on	on	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
3	3	CD	I-NP	O
and	and	CC	O	O
when	when	WRB	B-ADVP	O
her	her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
returned	return	VBD	B-VP	O
she	she	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
NPH	NPH	NN	B-NP	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
dosing	dosing	NN	I-NP	O
of	of	IN	B-PP	O
50	50	CD	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
and	and	CC	O	O
Regular	Regular	JJ	B-NP	O
14	14	CD	I-NP	O
moved	move	VBD	B-VP	O
up	up	RB	B-NP	O
to	to	TO	I-NP	O
17	17	CD	I-NP	O
units	unit	NNS	I-NP	O
b.i.d.	b.i.d.	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
to	to	TO	B-VP	O
cover	cover	VB	I-VP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
100s-low	100s-low	JJ	I-NP	O
200s	200	NNS	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
original	original	JJ	I-NP	O
outpatient	outpatient	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
70/30	70/30	CD	B-NP	O
70	70	CD	I-NP	O
units	unit	NNS	I-NP	O
b.i.d.	b.i.d.	RB	B-NP	O
3	3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Cardiopulmonary	Cardiopulmonary	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
hospital	hospital	NN	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
1	1	CD	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
started	start	VBD	B-VP	O
with	with	IN	B-PP	O
complaints	complaint	NNS	B-NP	O
of	of	IN	B-PP	O
cough	cough	NN	B-NP	O
and	and	CC	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
sort	sort	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
plus/minus	plus/minus	NN	I-NP	O
response	response	NN	I-NP	O
to	to	TO	B-PP	O
nebs	neb	NNS	B-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
and	and	CC	I-NP	O
smoking	smoking	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
small	small	JJ	B-NP	O
effusions	effusion	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
fluid	fluid	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
insulin	insulin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
bundle	bundle	NN	I-NP	O
branch	branch	NN	I-NP	O
block	block	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
new	new	JJ	B-ADJP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
in	in	IN	B-PP	O
2000	2000	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
then	then	RB	B-ADVP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
rule	rule	NN	I-NP	O
out	out	IN	B-PP	O
protocol	protocol	NN	B-NP	O
with	with	IN	B-PP	O
flat	flat	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
that	that	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
,	,	,	O	O
global	global	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-ADJP	O
to	to	TO	B-PP	O
severe	severe	JJ	B-NP	O
decrease	decrease	NN	I-NP	O
in	in	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
,	,	,	O	O
trace	trace	NN	B-NP	O
TR	TR	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
adenosine	adenosine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
to	to	TO	B-VP	O
show	show	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
reversible	reversible	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
defect	defect	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
diagonal	diagonal	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
distribution	distribution	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
global	global	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
simvastatin	simvastatin	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
LDL	LDL	NN	I-NP	I-protein
160s	160s	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Captopril	Captopril	NNP	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
LAD	LAD	NN	B-NP	B-protein
long	long	RB	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
RCA	RCA	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
27	27	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
by	by	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
and	and	CC	B-PP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
family	family	NN	I-NP	O
meeting	meeting	NN	I-NP	O
they	they	PRP	B-NP	O
decided	decide	VBD	B-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
with	with	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
CABG	CABG	NN	B-NP	O
decision	decision	NN	I-NP	O
and	and	CC	I-NP	O
planning	planning	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
Low	Low	JJ	B-NP	O
salt	salt	NN	I-NP	O
fluid	fluid	NN	I-NP	O
restricted	restricted	JJ	I-NP	O
diet	diet	NN	I-NP	O
in-house	in-house	NN	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gastritis	gastritis	NN	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
BUN	BUN	NN	B-NP	O
and	and	CC	I-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
turning	turn	VBG	I-VP	O
upward	upward	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
titration	titration	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
and	and	CC	I-VP	O
stabilized	stabilize	VBN	I-VP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	JJ	B-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
27	27	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
left	leave	VBN	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
going	go	VBG	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.q.d.	p.o.q.d.	NN	I-NP	O
and	and	CC	O	O
lisinopril	lisinopril	NN	B-NP	O
20	20	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
discharge	discharge	NN	I-NP	O
plan	plan	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
medically	medically	RB	B-VP	O
optimized	optimize	VBN	I-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
she	she	PRP	B-NP	O
makes	make	VBZ	B-VP	O
the	the	DT	B-NP	O
decision	decision	NN	I-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
in	in	IN	B-PP	O
that	that	DT	B-NP	O
direction	direction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
appointments	appointment	NNS	B-NP	O
with	with	IN	B-PP	O
both	both	CC	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Harland	Harland	NNP	I-NP	O
Isaman	Isaman	NNP	I-NP	O
and	and	CC	O	O
GYN	GYN	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Shewbridge	Shewbridge	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Clindamycin	Clindamycin	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
simvastatin	simvastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
lisinopril	lisinopril	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
atenolol	atenolol	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
aspirin	aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
;	;	:	O	O
insulin	insulin	NN	B-NP	O
70/30	70/30	CD	I-NP	O
70	70	CD	I-NP	O
units	unit	NNS	I-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
FOLLOWUP	FOLLOWUP	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Brehony	Brehony	NNP	I-NP	O
,	,	,	O	O
for	for	IN	B-SBAR	O
her	her	PRP	B-NP	O
to	to	TO	B-VP	O
call	call	VB	I-VP	O
and	and	CC	I-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
in	in	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Primary	Primary	JJ	B-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Loren	Loren	NNP	I-NP	O
Stivason	Stivason	NNP	I-NP	O
,	,	,	O	O
make	make	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ANTOINE	ANTOINE	NNP	B-NP	O
OAKS	OAKS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DQ37	DQ37	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BERNARDO	BERNARDO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
KUNAU	KUNAU	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
NW7	NW7	NNP	I-NP	O
GO009/821705	GO009/821705	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
15639	15639	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

UDIFY907IM	UDIFY907IM	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/4/02	1/4/02	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/4/02	1/4/02	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

GARRET	GARRET	NN	B-NP	O
ABOLT	ABOLT	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

WAYLON	WAYLON	NNP	B-NP	O
FRANCES	FRANCES	NNP	I-NP	O
MAIDONADO	MAIDONADO	NNP	I-NP	O
,	,	,	O	O
M.D	M.D	NNP	B-NP	O
.	.	.	O	O

